Skip to main content
Nucleic Acids Research logoLink to Nucleic Acids Research
. 1985 Oct 25;13(20):7395–7412. doi: 10.1093/nar/13.20.7395

Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II).

D J Beck, S Popoff, A Sancar, W D Rupp
PMCID: PMC322051  PMID: 3903663

Abstract

Mutants of Escherichia coli, which are blocked in excision repair (uvrA6, uvrB5, or uvrC34) are exceptionally sensitive to the antitumor drug cis-Pt(II)(NH3)2Cl2 (cis-DDP) but not the trans isomer. Plasmid DNA, damaged by either the cis or trans compound and treated with the UVRABC excision nuclease was cut as shown by conversion of supercoiled DNA to relaxed forms. All three protein products of the uvrA, uvrB, and uvrC genes were required for incision. End-labeled fragments damaged with cis-DDP and reacted with the UVRABC nuclease were cut at the 8th phosphodiester bond 5' and at the 4th phosphodiester bond 3' to adjacent GG's. DNA treated with trans-DDP was not cut appreciably at adjacent GG's by the repair enzyme as subsequent analysis of reaction products after enzyme digestion gave a pattern similar to those obtained with control untreated fragments. The results indicate that the UVRABC nuclease may promote cell survival by the removal of adjacent GG's which are crosslinked by cis-Pt(II)(NH3)2Cl2.

Full text

PDF
7395

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beck D. J., Brubaker R. R. Effect of cis-platinum(II)diamminodichloride on wild type and deoxyribonucleic acid repair deficient mutants of Escherichia coli. J Bacteriol. 1973 Dec;116(3):1247–1252. doi: 10.1128/jb.116.3.1247-1252.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Beck D. J., Fisch J. E. Mutagenicity of platinum coordination complexes in Salmonella typhimurium. Mutat Res. 1980 Jan;77(1):45–54. doi: 10.1016/0165-1218(80)90119-6. [DOI] [PubMed] [Google Scholar]
  3. Benedict W. F., Baker M. S., Haroun L., Choi E., Ames B. N. Mutagenicity of cancer chemotherapeutic agents in the Salmonella/microsome test. Cancer Res. 1977 Jul;37(7 Pt 1):2209–2213. [PubMed] [Google Scholar]
  4. Biggin M. D., Gibson T. J., Hong G. F. Buffer gradient gels and 35S label as an aid to rapid DNA sequence determination. Proc Natl Acad Sci U S A. 1983 Jul;80(13):3963–3965. doi: 10.1073/pnas.80.13.3963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brouwer J., van de Putte P., Fichtinger-Schepman A. M., Reedijk J. Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II). Proc Natl Acad Sci U S A. 1981 Nov;78(11):7010–7014. doi: 10.1073/pnas.78.11.7010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cohen G. L., Bauer W. R., Barton J. K., Lippard S. J. Binding of cis- and trans-dichlorodiammineplatinum(II) to DNA: evidence for unwinding and shortening of the double helix. Science. 1979 Mar 9;203(4384):1014–1016. doi: 10.1126/science.370979. [DOI] [PubMed] [Google Scholar]
  7. Cunningham D., Pembroke J. T., Stevens E. cis-Platinum(II)diamminodichloride-induced mutagenesis in E. coli K12: crowding depression of mutagenesis. Mutat Res. 1981 Dec;84(2):273–282. doi: 10.1016/0027-5107(81)90197-4. [DOI] [PubMed] [Google Scholar]
  8. Eastman A. Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). Biochemistry. 1983 Aug 2;22(16):3927–3933. doi: 10.1021/bi00285a031. [DOI] [PubMed] [Google Scholar]
  9. Fichtinger-Schepman A. M., van der Veer J. L., den Hartog J. H., Lohman P. H., Reedijk J. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation. Biochemistry. 1985 Jan 29;24(3):707–713. doi: 10.1021/bi00324a025. [DOI] [PubMed] [Google Scholar]
  10. Filipski J., Kohn K. W., Prather R., Bonner W. M. Thiourea reverses cross-links and restores biological activity in DNA treated with dichlorodiaminoplatinum (II). Science. 1979 Apr 13;204(4389):181–183. doi: 10.1126/science.571145. [DOI] [PubMed] [Google Scholar]
  11. Fraval H. N., Rawlings C. J., Roberts J. J. Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus. Mutat Res. 1978 Jul;51(1):121–132. doi: 10.1016/0027-5107(78)90014-3. [DOI] [PubMed] [Google Scholar]
  12. Harder H. C., Rosenberg B. Inhibitory effects of anti-tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in virtro. Int J Cancer. 1970 Sep 15;6(2):207–216. doi: 10.1002/ijc.2910060207. [DOI] [PubMed] [Google Scholar]
  13. Markham B. E., Brubaker R. R. Influence of chromosome integrity on Escherichia coli cell division. J Bacteriol. 1980 Jul;143(1):455–462. doi: 10.1128/jb.143.1.455-462.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Marusyk R., Sergeant A. A simple method for dialysis of small-volume samples. Anal Biochem. 1980 Jul 1;105(2):403–404. doi: 10.1016/0003-2697(80)90477-7. [DOI] [PubMed] [Google Scholar]
  15. Mong S., Daskal Y., Prestayko A. W., Crooke S. T. DNA supercoiling, shortening, and induction of single-strand regions by cis-diamminedichloroplatinum(II). Cancer Res. 1981 Oct;41(10):4020–4026. [PubMed] [Google Scholar]
  16. Rosenberg B., VanCamp L., Trosko J. E., Mansour V. H. Platinum compounds: a new class of potent antitumour agents. Nature. 1969 Apr 26;222(5191):385–386. doi: 10.1038/222385a0. [DOI] [PubMed] [Google Scholar]
  17. Royer-Pokora B., Gordon L. K., Haseltine W. A. Use of exonuclease III to determine the site of stable lesions in defined sequences of DNA: the cyclobutane pyrimidine dimer and cis and trans dichlorodiammine platinum II examples. Nucleic Acids Res. 1981 Sep 25;9(18):4595–4609. doi: 10.1093/nar/9.18.4595. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sancar A., Rupp W. D. A novel repair enzyme: UVRABC excision nuclease of Escherichia coli cuts a DNA strand on both sides of the damaged region. Cell. 1983 May;33(1):249–260. doi: 10.1016/0092-8674(83)90354-9. [DOI] [PubMed] [Google Scholar]
  19. Sancar A., Rupp W. D. Physical map of the recA gene. Proc Natl Acad Sci U S A. 1979 Jul;76(7):3144–3148. doi: 10.1073/pnas.76.7.3144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sancar A., Stachelek C., Konigsberg W., Rupp W. D. Sequences of the recA gene and protein. Proc Natl Acad Sci U S A. 1980 May;77(5):2611–2615. doi: 10.1073/pnas.77.5.2611. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Sancar G. B., Sancar A., Little J. W., Rupp W. D. The uvrB gene of Escherichia coli has both lexA-repressed and lexA-independent promoters. Cell. 1982 Mar;28(3):523–530. doi: 10.1016/0092-8674(82)90207-0. [DOI] [PubMed] [Google Scholar]
  22. Scovell W. M., Capponi V. J. S1 nuclease sensitivity to cis- and trans-diamminedichloroplatinum(II) modified DNAS: influence of (G+C) content and nucleotide sequence. Biochem Biophys Res Commun. 1984 Oct 30;124(2):367–374. doi: 10.1016/0006-291x(84)91562-6. [DOI] [PubMed] [Google Scholar]
  23. Stone P. J., Kelman A. D., Sinex F. M. Resolution of alpha, beta and gamma DNA of Saccharomyces cerevisiae with the antitumor drug cis-Pt (NH3)2CL2. Evidence for preferential drug binding by GpG sequences of DNA. J Mol Biol. 1976 Jul 15;104(4):793–801. doi: 10.1016/0022-2836(76)90182-0. [DOI] [PubMed] [Google Scholar]
  24. Stone P. J., Kelman A. D., Sinex F. M. Specific binding of antitumour drug cis-Pt(NH3)2C12 to DNA rich in guanine and cytosine. Nature. 1974 Oct 25;251(5477):736–737. doi: 10.1038/251736a0. [DOI] [PubMed] [Google Scholar]
  25. Tullius T. D., Lippard S. J. Ethidium bromide changes the nuclease-sensitive DNA binding sites of the antitumor drug cis-diamminedichloroplatinum(II). Proc Natl Acad Sci U S A. 1982 Jun;79(11):3489–3492. doi: 10.1073/pnas.79.11.3489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Uhlin B. E., Molin S., Gustafsson P., Nordström K. Plasmids with temperature-dependent copy number for amplification of cloned genes and their products. Gene. 1979 Jun;6(2):91–106. doi: 10.1016/0378-1119(79)90065-9. [DOI] [PubMed] [Google Scholar]
  27. Wiencke J. K., Cervenka J., Paulus H. Mutagenic activity of anticancer agent cis-dichlorodiammine platinum-II. Mutat Res. 1979 Sep;68(1):69–77. doi: 10.1016/0165-1218(79)90079-x. [DOI] [PubMed] [Google Scholar]

Articles from Nucleic Acids Research are provided here courtesy of Oxford University Press

RESOURCES